These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3664090)

  • 21. Role of platelet-activating factor (PAF) and prostaglandins in colonic motor and secretory disturbances induced by Escherichia coli endotoxin in conscious rats.
    Pons L; Droy-Lefaix MT; Buéno L
    Prostaglandins; 1994 Feb; 47(2):123-36. PubMed ID: 8016383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effects of dexamethasone in endotoxic shock and its relation to PAF-acether synthesis in the gastrointestinal tract and lung.
    Ibbotson GC; Wallace JL
    J Lipid Mediat; 1989; 1(5):273-82. PubMed ID: 2519897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of platelet-activating factor in endotoxin-induced priming of rabbit polymorphonuclear leukocytes.
    Stewart AG; Harris T
    J Lipid Mediat; 1991; 3(2):125-38. PubMed ID: 1665713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endotoxins stimulate neutrophil adhesion followed by synthesis and release of platelet-activating factor in microparticles.
    Watanabe J; Marathe GK; Neilsen PO; Weyrich AS; Harrison KA; Murphy RC; Zimmerman GA; McIntyre TM
    J Biol Chem; 2003 Aug; 278(35):33161-8. PubMed ID: 12810708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats.
    Natsume Y; Imanishi N; Koike H; Morooka S
    Arzneimittelforschung; 1994 Nov; 44(11):1208-13. PubMed ID: 7848333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
    Etienne A; Hecquet F; Guilmard C; Soulard C; Braquet P
    Int J Tissue React; 1987; 9(1):19-26. PubMed ID: 3596954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: studies with FR-900452, a specific inhibitor of PAF.
    Okamoto M; Yoshida K; Nishikawa M; Kohsaka M; Aoki H
    Thromb Res; 1986 Jun; 42(5):661-71. PubMed ID: 3754990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic and regional hemodynamic changes during endotoxin or platelet activating factor (PAF)-induced shock in rats.
    Mulder MF; van Lambalgen AA; van Kraats AA; Scheffer PG; Bouman AA; van den Bos GC; Thijs LG
    Circ Shock; 1993 Dec; 41(4):221-9. PubMed ID: 8143350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models of hypotension in the rat and dog.
    Handley DA; Van Valen RG; Tomesch JC; Melden MK; Jaffe JM; Ballard FH; Saunders RN
    Immunopharmacology; 1987 Apr; 13(2):125-32. PubMed ID: 3597060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of neuropeptide FF on intestinal motility and temperature changes induced by endotoxin and platelet-activating factor.
    Million M; Fioramonti J; Zajac JM; Buéno L
    Eur J Pharmacol; 1997 Sep; 334(1):67-73. PubMed ID: 9346330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Essential fatty acid-deficient diet modifies PAF levels in stomach and duodenum of endotoxin-treated rats.
    Autore G; Cicala C; Cirino G; Maiello FM; Mascolo N; Capasso F
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):145-53. PubMed ID: 8012761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor (TNF) and endotoxin prime effects of PAF in vivo.
    Heuer HO; Letts G; Meade CJ
    J Lipid Mediat; 1990; 2 Suppl():S101-8. PubMed ID: 2133276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-activating factor (PAF-acether) formation in neonatal intestinal mucosa and in cultured intestinal epithelial cells.
    Kald B; Gustafson C; Franzén L; Weström B; Sjödahl R; Tagesson C
    Eur Surg Res; 1992; 24(6):325-32. PubMed ID: 1292936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.
    Fletcher JR; DiSimone AG; Earnest MA
    Ann Surg; 1990 Mar; 211(3):312-6. PubMed ID: 2178565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia.
    Hsueh W; González-Crussi F; Arroyave JL
    FASEB J; 1987 Nov; 1(5):403-5. PubMed ID: 3678700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The roles of platelet activating factor in intestinal mucosal barrier injury after burn].
    Yu P; Xiao G; Fu W
    Zhonghua Wai Ke Za Zhi; 1995 Jul; 33(7):393-5. PubMed ID: 8565724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats.
    Wang J; Dunn MJ
    Am J Physiol; 1987 Dec; 253(6 Pt 2):F1283-9. PubMed ID: 2827506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-activating factor and endotoxin activate CCAAT/enhancer binding protein in rat small intestine.
    Wang H; Qu X; De Plaen IG; Hsueh W
    Br J Pharmacol; 2001 Jul; 133(5):713-21. PubMed ID: 11429396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
    Zhou WG; Chao W; Levine BA; Olson MS
    Am J Pathol; 1990 Dec; 137(6):1501-8. PubMed ID: 1701964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-activating factor increases mucosal permeability in rat intestine via tyrosine phosphorylation of E-cadherin.
    Tan XD; Chang H; Qu XW; Caplan M; Gonzalez-Crussi F; Hsueh W
    Br J Pharmacol; 2000 Apr; 129(7):1522-9. PubMed ID: 10742310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.